Raily Aesthetic Medicine Delays Utilization of Proceeds Amid COVID-19 ChallengesTip Ranks·Oct 10, 2025 at 08:41 AM029350.00%029300.00%
"Performance" RAILY AESMED's half-year loss expanded to 7.57 million RMBAASTOCKS·Sep 1, 2025 at 03:44 AM029350.00%029300.00%
RAILY AESMED released its interim results, with a loss attributable to shareholders of 7.57 million yuan, an increase of 368.15% year-on-yearZhitong·Aug 29, 2025 at 12:55 PM029300.00%029350.00%
Raily Aesthetic Medicine Schedules Board Meeting for Interim ResultsTip Ranks·Aug 19, 2025 at 09:25 AM029350.00%029300.00%
RAILY AESMED and Hangzhou Bellephile terminate contract arrangementAASTOCKS·Aug 15, 2025 at 09:07 AM029350.00%029300.00%
"Profit Warning" RAILY AESMED estimates mid-term losses to expand to 8 million RMBAASTOCKS·Aug 10, 2025 at 08:27 AM029350.00%029300.00%
RAILY AESMED issued a profit warning, expecting a mid-term loss attributable to shareholders of approximately 8 million yuan, an increase compared to the same period last yearZhitong·Aug 8, 2025 at 10:38 AM029300.00%029350.00%
RAILY AESMED introduces external capital for Hainan Belleville ClinicZhitong·Jul 4, 2025 at 12:42 PM029350.00%029300.00%
Some Shareholders May Object To A Pay Rise For Raily Aesthetic Medicine International Holdings Limited's (HKG:2135) CEO This YearSimplywall·May 23, 2025 at 11:35 PM029350.00%029300.00%
RAILY AESMED issues a profit warning, expecting a loss attributable to shareholders of approximately HKD 59 million in 2024Zhitong·Mar 10, 2025 at 02:44 PM029300.00%029350.00%
Raily Aesthetic Medicine Forms Strategic Investment CommitteeTip Ranks·Dec 29, 2024 at 11:37 PM029350.00%029300.00%